We have previously shown that selumetinib, an MEK inhibitor recently approved for treatment of NF1-associated neurofibromas, reaches higher concentrations in the brain of NF1 minipigs compared with WT minipigs, which may be due to alterations in the blood-brain barrier.10 The gene discussed is MAP2K7; the disease is neurofibroma.